AR043046A1 - AMBO COMPOUNDS OF CARBOXILIC ACID WITH ANTAGONIC EFFECT OF HCM, MEDICATIONS CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION - Google Patents
AMBO COMPOUNDS OF CARBOXILIC ACID WITH ANTAGONIC EFFECT OF HCM, MEDICATIONS CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATIONInfo
- Publication number
- AR043046A1 AR043046A1 ARP030103034A ARP030103034A AR043046A1 AR 043046 A1 AR043046 A1 AR 043046A1 AR P030103034 A ARP030103034 A AR P030103034A AR P030103034 A ARP030103034 A AR P030103034A AR 043046 A1 AR043046 A1 AR 043046A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- group
- phenyl
- atoms
- independently
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/24—Camphidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/26—Benzomorphans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Compuestos de amida de ácido carboxílico de fórmula general (1) en la cual R1, R2 son, de modo independiente entre sí, H, un grupo alquilo C1-8 o cicloalquilo C3-7, opcionalmente sustituido con el radical R11 o un radical fenilo opcionalmente mono o polisustituido con el radical R12 y/o monosustituido con nitro, o R1 y R2 forman un puente alquileno C2-8, en el cual --uno o dos grupos -CH2 pueden estar reemplazados, de modo independiente entre sí, por -CH=N- ó -CH=CH- y/o uno o dos grupos -CH2 pueden estar reemplazados, de modo independiente entre sí por -O-, -S-, -CO-, -C(=CH2)- ó -NR13 de modo tal que los heteroátomos no estén unidos entre sí de manera directa, donde en el puente alquileno definido con anterioridad pueden estar reemplazados uno o varios átomos de H con R14, y/o donde el puente alquileno definido con anterioridad puede estar sustituido con uno o dos grupos C y carbo- o heterocíclicos iguales o diferentes de modo tal que la unión entre el puente de alquileno y el grupo Cy se realiza a través de un enlace simple o doble, a través de un átomo de C común, conformando un sistema de anillo espirocíclico, a través de dos átomos de C y/o N comunes adyacentes, conformando un sistema de anillo bicíclico condensado o a través de tres o más átomos de C y/o N, conformando un sistema de anillo puenteado; R3 es H, alquilo C1-6, cicloalquilo C3-7, cicloalquil C3-7-alquilo C1-4, cicloalquenilo C3-7, cicloalquenil C3-7-alquilo C1-4, fenilo, fenilalquilo C1-4, alcoxi C1-3-alquilo C2-6, aminoalquilo C2-6, alquil C1-3- aminoalquilo C2-6 ó di-(alquil C1-3)-aminoalquilo C2-6; X es un enlace simple o un puente alquileno C1-8, en el cual --uno o dos grupos -CH2 pueden estar reemplazados, de modo independiente entre sí, por -CH=CH- ó -C:::C- y/o --uno o dos grupos -CH2 pueden estar reemplazados, de modo independiente entre sí, por -O-, -S-, -(SO)-, -(SO2)-, -CO- ó -NR4- de manera tal que dos átomos de O, S ó N ó un átomo de O no estén unidos entre sí de forma directa con un átomo de S, donde uno o dos átomos de C pueden estar sustituidos, de modo independiente entre sí, por un radical hidroxi, omega-hidroxialquilo C1-3, omega-(alcoxi C1-3)-alquilo C1-3 y/o alcoxi C1-3, y/o por uno o dos radicales alquilo C1-6 iguales o diferentes, y/o donde el puente alquileno puede estar unido con R1, incluyendo el átomo de N unido con R1 y X, conformando un grupo heterocíclico; Z es un puente alquileno C1-4, donde dos átomos de C adyacentes pueden estar unidos entre sí con un puente alquileno C1-4 adicional, donde en el grupo Z un grupo -CH2 puede estar reemplazado por -O- ó -NR5-, donde uno o dos átomos de C del puente alquileno pueden estar sustituidos, de modo independiente entre sí, con un radical hidroxi, omega-hidroxialquilo C1-3, omega-(alcoxi C1-3)-alquilo C1-3, alcoxi C1-3, aminoalquilo C1-3, alquil C1-3-aminoalquilo C1-3, ó di-(alquil C1-3)-aminoalquilo C1-3 y/o por uno o dos radicales alquilo C1-6 iguales o diferentes, y/o donde R3 puede estar unido con Z, incluyendo el átomo de N unido con R3, conformando un grupo heterocíclico; A, Y tienen, de modo independiente entre sí, uno de los significados indicados para C y, donde R1 puede estar unido con Y, incluyendo el grupo X y el átomo de N unido con R1 y X, conformando un grupo heterocíclico condensado en Y, y/o donde R3 puede estar unido con Y, incluyendo el grupo Z y el átomo de N unido con R3 y Z , conformando un grupo heterocíclico condensado en Y, saturado o parcialmente no saturado, o donde A y R3 pueden estar unidos entre sí de modo tal que el grupo -NR3-CO-A- de la fórmula (1) signifique un grupo de la fórmula (2) y Q significa un grupo seleccionado de las subfórmulas: -CR6R7-, -CR6=R7-, -N=CR8-, -N=N-, -CO-NR9-, -CR8=N-, -CO-; L1, L2, L3 tienen, de modo independiente entre sí, uno de los significados indicados para R20; B es alquilo C1-6, alquenilo C1-6, alquinilo C1-6, cicloalquil C3-7-alquilo C1-3, cicloalquenil C3-7-alquilo C1-3, cicloalquil C3-7-alquenilo C1-3 ó cicloalquil C3-7-alquinilo C1-3, donde uno o varios átomos de C pueden estar mono o polisustituidos con halógeno y/o monosustituidos con hidroxi o ciano y/o grupos cíclicos pueden estar mono o polisustituidos con R20, o uno de los significados para Cy, donde la unión con el grupo W u opcionalmente en forma directa con el grupo A se realiza a través de un átomo de C de la parte carbocíclica o del anillo fenilo o piridina opcionalmente condensado o a través de un átomo de N ó C de la parte heterocíclica, donde para el caso de que k = 0, el grupo B puede estar unido entre sí con el grupo A a través de un átomo de C común conformando un sistema de anillo espirocíclico o a través de dos átomos comunes adyacentes, conformando un sistema de anillos bicíclicos condensados; W es un enlace simple, -O-, un grupo alquileno C1-4, alquenileno C2-4, alquinileno C2-4, alquilenoxi C1-4, oxi-alquileno C1-4, oxi-alquilen C1-3-alquileno C1-3, imino, N-(alquil C1-3)-imino, imino-alquileno C1-4, N-(alquil C1-3)-imino-alquileno C1-4, alquilen-imino C1-4 ó alquilen C1-4-N-(alquil C1-3)-imino, donde uno o dos átomos de C pueden estar sustituidos, de modo independiente entre sí, con un radical hidroxi, omega-hidroxi alquilo C1-3, omega-(alcoxi C1-3)-alquilo C1-3 y/o alcoxi C1-3 y/o con uno o dos radicales alquilo C1-6 iguales o diferentes, y/o donde W en los significados alquileno, oxialquileno y alquilenoxialquileno también pueden estar unidos con B en el significado Cy a través de un enlace doble; k es 0 ó 1; Cy es un grupo carbo- o heterocíclico seleccionado de uno de los siguientes significados: un grupo carbocíclico saturado de 3 a 7 miembros, un grupo carbocíclico no saturado de 5 a 7 miembros, un grupo fenilo, un grupo heterocíclico saturado de 4 a 7 miembros o no saturado de 5 a 7 miembros con un átomo de N, O ó S como heteroátomo, un grupo heterocíclico saturado o no saturado de 5 a 7 miembros con dos o más átomos de N o con uno o dos átomos de N y un átomo de O ó S como heteroátomos, un grupo aromático heterocíclico de 5 ó 6 miembros con uno o varios heteroátomos iguales o diferentes seleccionados de N, O y/o S, donde los grupos de 5, 6 ó 7 miembros detallados con anterioridad pueden estar unidos en forma condensada a través de dos átomos de C comunes adyacentes con un anillo fenilo o piridina, y donde en los grupos de 5, 6 ó 7 miembros mencionados con anterioridad uno o dos grupos -CH2 no adyacentes pueden estar sustituidos con un grupo -CO-, -C(=CH2)-, -(SO)- ó -(SO2), y donde los grupo saturados de 6 ó 7 miembros detallados con anterioridad también pueden estar presentes como sistemas de anillos puenteados con un puente imino, N-(alquil C1-4)-imino, metileno, (alquil C1-4)-metileno ó di-(alquil C1-4)-metileno, y donde los grupos cíclicos mencionados con anterioridad pueden estar mono o polisustituidos en uno o varios átomos de C con R20, en el caso de un grupo fenilo adicionalmente también monosustituido con nitro, y/o en uno o varios átomos de N con R21; R4, R5 tienen, de modo independiente entre sí, uno de los significados indicados para R16; R6, R7, R8, R9 son, de modo independiente entre sí, H, un grupo alquilo C1-6, omega-alcoxi C1-3-alquilo C1-3 ó omega-hidroxialquilo C1-3 y R6, R7,R8 también son, de modo independiente entre sí, halógeno; R11 es R15-O-, R15-O-CO, R16R17N-, R18R19NCO- ó Cy-; R12 tiene uno de los significados indicados para R20; R13 tiene uno de los significados indicados para R17; R14 es halógeno, alquilo C1-6, R15-O-, R15-O-CO-, R16R17N-, R18R19N-CO-, R15-O-alquilo C1-3, R15-O-CO-alquilo C1-3, R16R17N-alquilo C1-3, R18R19N-CO-alquilo C1-3 ó Cy-alquilo C1-3; R15 es H, alquilo C1-4, cicloalquilo C3-7, cicloalquil C3-7-alquilo C1-3, fenilo, fenil-alquilo C1-3 o piridinilo; R16 es H, alquilo C1-6, cicloalquilo C3-7, cicloalquil C3-7-alquilo C1-3, cicloalquenilo C4-7, cicloalquenil C4-7-alquilo C1-3, omega-hidroxialquilo C2-3, omega-(alcoxi C1-3)-alquilo C2-3, aminoalquilo C1-6, alquil C1-3-amino-alquilo C1-6 ó di-(alquil C1-3)-amino-alquilo C1-6; R17 tiene uno de los significados indicados para R16 o es fenilo, fenil-alquilo C1-3, piridinilo, dioxolan-2-ilo, alquilcarbonilo C1-3, hidroxicarbonil-alquilo C1-3, alcoxicarbonilo C1-4, alquil C1-3-carbonilamino-alquilo C2-3, alquilsulfonilo C1-3 ó alquil C1-3-sulfonilamino-alquilo C2-3; R18, R19 son, de modo independiente entre sí, H ó alquilo C1-6; R20 es halógeno, hidroxi, ciano, alquilo C1-4, cicloalquilo C3-7, hidroxialquilo C1-3, R22-alquilo C1-3 ó tiene uno de los significados indicados para R22; R21 es alquilo C1-3, omega-hidroxi-alquilo C2-3, fenilo, fenil-alquilo C1-3, alquilcarbonilo C1-3, carboxi, alcoxicarbonilo C1-4, alquilsulfonilo C1-3, fenilcarbonilo o fenil-alquil-carbonilo C1-3; R22 es piridinilo, fenilo, fenil-alcoxi C1-3, alcoxi C1-3, alquiltio C1-3, carboxi, H-CO-, alquilcarbonilo C1-3, alcoxicarbonilo C1-4, aminocarbonilo, alquilaminocarbonilo C1-3, di-(alquil C1-3)-aminocarbonilo, alquilsulfonilo C1-3, alquilsulfinilo C1-3, alquilsulfonilamino C1-3, amino, alquilamino C1-3, di-(alquil C1-3)-amino, fenil-alquilamino C1-3, ó N-(alquil C1-3)-fenil-alquilamino C1-3, acetilamino, propionilamino, fenilcarbonilo, fenilcarbonilamino, fenilcarbonilmetilamino, hidroxialquilaminocarbonilo, (4-morfolinil)carbonilo, (1-pirrolidinil)-carbonilo, (1-piperidinil)-carbonilo, (hexahidro-1-azepinil)carbonilo, (4-metil-1-piperazinil)carbonilo, metilendioxi, aminocarbonilamino o alquilaminocarbonilamino, donde en los grupo y radicales A, B, W, X, Y, Z, R1 a R9 y R11 a R22, uno o varios átomos de C pueden estar mono o polisustituidos con F y/o uno o dos átomos de C pueden estar, de modo independiente entre sí, monosustituidos con Cl ó Br, y/o uno o varios anillos fenilo presentan, de modo independiente entre sí, adicionalmente uno, dos o tres sustituyentes seleccionados del grupo F, Cl, Br, I, alquilo C1-4, alcoxi C1-4, difluorometil-, trifluorometil-, hidroxi-, amino, alquilamino C1-3, di-(alquil C1-3)-amino, acetilamino, aminocarbonilo, CN, difluoromCarboxylic acid amide compounds of the general formula (1) in which R 1, R 2 are, independently of each other, H, a C 1-8 alkyl or C 3-7 cycloalkyl group, optionally substituted with the radical R 11 or a phenyl radical optionally mono or polysubstituted with the radical R12 and / or monosubstituted with nitro, or R1 and R2 form a C2-8 alkylene bridge, in which - one or two -CH2 groups can be replaced, independently of each other, by - CH = N- or -CH = CH- and / or one or two -CH2 groups can be replaced, independently of each other by -O-, -S-, -CO-, -C (= CH2) - or - NR13 so that the heteroatoms are not directly linked to each other, where one or more H atoms with R14 can be replaced in the above-defined alkylene bridge, and / or where the previously defined alkylene bridge can be substituted with one or two C and carbocyclic or heterocyclic groups the same or different such that the junction between the rental bridge no and the group Cy is made through a single or double bond, through a common C atom, forming a spirocyclic ring system, through two adjacent common C and / or N atoms, forming a system of bicyclic ring condensed or through three or more atoms of C and / or N, forming a bridged ring system; R3 is H, C1-6 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl-C1-4 alkyl, C3-7 cycloalkenyl, C3-7 cycloalkenyl-C1-4 alkyl, phenyl, phenyl C1-4 alkyl, C1-3 alkoxy -C2-6 alkyl, C2-6 aminoalkyl, C1-3 alkyl-C2-6 aminoalkyl or di- (C1-3 alkyl) -C2-6 aminoalkyl; X is a single bond or a C1-8 alkylene bridge, in which - one or two -CH2 groups can be replaced, independently of each other, by -CH = CH- or -C ::: C- and / or - one or two groups -CH2 can be replaced, independently of each other, by -O-, -S-, - (SO) -, - (SO2) -, -CO- or -NR4- in such a way that two atoms of O, S or N or an atom of O are not directly connected to each other with an atom of S, where one or two atoms of C can be substituted, independently of each other, by a hydroxy radical, omega-C1-3 hydroxyalkyl, omega- (C1-3 alkoxy) -C1-3 alkyl and / or C1-3 alkoxy, and / or by one or two C1-6 alkyl radicals the same or different, and / or where the bridge alkylene may be linked with R1, including the N atom attached with R1 and X, forming a heterocyclic group; Z is a C1-4 alkylene bridge, where two adjacent C atoms can be linked together with an additional C1-4 alkylene bridge, where in group Z a group -CH2 can be replaced by -O- or -NR5-, where one or two C atoms of the alkylene bridge can be substituted, independently of each other, with a hydroxy radical, omega-hydroxyalkyl C1-3, omega- (C1-3 alkoxy) -alkyl C1-3, alkoxy C1-3 , C1-3 aminoalkyl, C1-3alkyl-C1-3alkylalkyl, or di- (C1-3alkyl) -C1-3alinoalkyl and / or by one or two same or different C1-6 alkyl radicals, and / or where R3 may be linked to Z, including the N atom attached to R3, forming a heterocyclic group; A, Y have, independently of each other, one of the meanings indicated for C and, where R1 can be linked with Y, including the group X and the atom of N linked with R1 and X, forming a heterocyclic group fused to Y , and / or where R3 can be linked with Y, including the group Z and the atom of N linked with R3 and Z, forming a heterocyclic group fused to Y, saturated or partially unsaturated, or where A and R3 can be linked between yes so that the group -NR3-CO-A- of the formula (1) means a group of the formula (2) and Q means a group selected from the sub-formulas: -CR6R7-, -CR6 = R7-, - N = CR8-, -N = N-, -CO-NR9-, -CR8 = N-, -CO-; L1, L2, L3 have, independently of one another, one of the meanings indicated for R20; B is C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, C3-7 cycloalkyl-C1-3 alkyl, C3-7 cycloalkenyl-C1-3 alkyl, C3-7 cycloalkyl-C1-3 alkenyl or C3- cycloalkyl 7-C 1-3 alkynyl, where one or more C atoms may be mono or polysubstituted with halogen and / or monosubstituted with hydroxy or cyano and / or cyclic groups may be mono or polysubstituted with R20, or one of the meanings for Cy, where the union with the group W or optionally directly with the group A is carried out through a C atom of the carbocyclic part or the optionally condensed phenyl or pyridine ring or through a N or C atom of the heterocyclic part , where in the case that k = 0, group B can be linked together with group A through a common C atom forming a spirocyclic ring system or through two adjacent common atoms, forming a ring system condensed bicyclics; W is a single bond, -O-, a C1-4 alkylene group, C2-4 alkenylene, C2-4 alkynylene, C1-4 alkylenoxy, C1-4 oxy-alkylene, C1-3 oxy-C1-3 alkylene-C1-3 alkylene , imino, N- (C1-3 alkyl) -imino, imino-C1-4 alkylene, N- (C1-3 alkyl) -imino-C1-4 alkylene, C1-4 alkylene-imino or C1-4-N alkylene - (C1-3 alkyl) -imino, where one or two C atoms can be substituted, independently of each other, with a hydroxy radical, omega-hydroxy C1-3 alkyl, omega- (C1-3 alkoxy) -alkyl C1-3 and / or C1-3 alkoxy and / or with one or two C1-6 alkyl radicals the same or different, and / or where W in the meanings alkylene, oxyalkylene and alkyleneoxyalkylene may also be linked with B in the meaning Cy to through a double bond; k is 0 or 1; Cy is a carbo- or heterocyclic group selected from one of the following meanings: a saturated carbocyclic group of 3 to 7 members, an unsaturated carbocyclic group of 5 to 7 members, a phenyl group, a saturated heterocyclic group of 4 to 7 members or unsaturated 5 to 7 members with an atom of N, O or S as a heteroatom, a saturated or unsaturated heterocyclic group of 5 to 7 members with two or more N atoms or with one or two N atoms and one atom of O or S as heteroatoms, a 5- or 6-membered heterocyclic aromatic group with one or more identical or different heteroatoms selected from N, O and / or S, where the groups of 5, 6 or 7 members detailed above may be linked in condensed form through two adjacent common C atoms with a phenyl or pyridine ring, and where in the groups of 5, 6 or 7 members mentioned above one or two non-adjacent -CH2 groups may be substituted with a -CO group -, -C (= CH2) -, - (SO) - or - (SO2), and where saturated groups of 6 or 7 members detailed above may also be present as bridged ring systems with an imino bridge, N- (C1-4 alkyl) -imino, methylene, (C1- alkyl 4) -methylene or di- (C1-4 alkyl) -methylene, and where the aforementioned cyclic groups may be mono- or polysubstituted in one or more C atoms with R20, in the case of a phenyl group additionally also monosubstituted with nitro, and / or in one or several atoms of N with R21; R4, R5 have, independently of one another, one of the meanings indicated for R16; R6, R7, R8, R9 are, independently of each other, H, a C1-6 alkyl, omega-C1-3 alkoxy-C1-3 alkyl or omega-hydroxy C1-3 alkyl and R6, R7, R8 are also , independently of each other, halogen; R11 is R15-O-, R15-O-CO, R16R17N-, R18R19NCO- or Cy-; R12 has one of the meanings indicated for R20; R13 has one of the meanings indicated for R17; R14 is halogen, C1-6 alkyl, R15-O-, R15-O-CO-, R16R17N-, R18R19N-CO-, R15-O-C1-3 alkyl, R15-O-CO-C1-3 alkyl, R16R17N -C1-3 alkyl, R18R19N-CO-C1-3 alkyl or Cy-C1-3 alkyl; R 15 is H, C 1-4 alkyl, C 3-7 cycloalkyl, C 3-7 cycloalkyl-C 1-3 alkyl, phenyl, phenyl-C 1-3 alkyl or pyridinyl; R16 is H, C1-6 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl-C1-3 alkyl, C4-7 cycloalkenyl, C4-7 cycloalkenyl-C1-3 alkyl, omega-C2-3 hydroxyalkyl, omega- (alkoxy C1-3) -C2-3alkyl, C1-6 aminoalkyl, C1-3alkyl-C1-6alkyl or di- (C1-3alkyl) -amino-C1-6alkyl; R17 has one of the meanings indicated for R16 or is phenyl, phenyl-C1-3 alkyl, pyridinyl, dioxolan-2-yl, C1-3 alkylcarbonyl, hydroxycarbonyl-C1-3 alkyl, C1-4 alkoxycarbonyl, C1-3 alkyl carbonylamino-C2-3 alkyl, C1-3 alkylsulfonyl or C1-3 alkyl-sulfonylamino-C2-3 alkyl; R18, R19 are, independently of each other, H or C1-6 alkyl; R20 is halogen, hydroxy, cyano, C1-4 alkyl, C3-7 cycloalkyl, C1-3 hydroxyalkyl, R22-C1-3 alkyl or has one of the meanings indicated for R22; R21 is C1-3 alkyl, omega-hydroxy-C2-3 alkyl, phenyl, phenyl C1-3 alkyl, C1-3 alkylcarbonyl, carboxy, C1-4 alkoxycarbonyl, C1-3 alkylsulfonyl, phenylcarbonyl or phenylC1 alkylcarbonyl -3; R22 is pyridinyl, phenyl, C1-3 phenyl-alkoxy, C1-3 alkoxy, C1-3 alkylthio, carboxy, H-CO-, C1-3 alkylcarbonyl, C1-4 alkoxycarbonyl, aminocarbonyl, C1-3 alkylaminocarbonyl, di- ( C1-3 alkyl) -aminocarbonyl, C1-3 alkylsulfonyl, C1-3 alkylsulfinyl, C1-3 alkylsulfonylamino, amino, C1-3 alkylamino, di- (C1-3 alkyl) -amino, phenyl-C1-3 alkylamino, or N - (C1-3 alkyl) -phenyl-C1-3 alkylamino, acetylamino, propionylamino, phenylcarbonyl, phenylcarbonylamino, phenylcarbonylmethylamino, hydroxyalkylaminocarbonyl, (4-morpholinyl) carbonyl, (1-pyrrolidinyl) -carbonyl, (1-piperidinyl) -carbonyl, (hexahydro-1-azepinyl) carbonyl, (4-methyl-1-piperazinyl) carbonyl, methylenedioxy, aminocarbonylamino or alkylaminocarbonylamino, where in the groups and radicals A, B, W, X, Y, Z, R1 to R9 and R11 a R22, one or more C atoms may be mono or polysubstituted with F and / or one or two C atoms may be, independently of each other, monosubstituted with Cl or Br, and / or one or more phenyl rings pr they independently contain one, two or three substituents selected from the group F, Cl, Br, I, C1-4 alkyl, C1-4 alkoxy, difluoromethyl-, trifluoromethyl-, hydroxy-, amino, C1- alkylamino 3, di- (C1-3 alkyl) -amino, acetylamino, aminocarbonyl, CN, difluorom
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10238865A DE10238865A1 (en) | 2002-08-24 | 2002-08-24 | New carboxamides are melanin-concentrating hormone receptor antagonists, useful for treating e.g. metabolic diseases, diabetes, eating disorders, cardiovascular disease, emotional disorders, reproductive and memory disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043046A1 true AR043046A1 (en) | 2005-07-13 |
Family
ID=31501914
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030103034A AR043046A1 (en) | 2002-08-24 | 2003-08-22 | AMBO COMPOUNDS OF CARBOXILIC ACID WITH ANTAGONIC EFFECT OF HCM, MEDICATIONS CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP1534689A1 (en) |
JP (1) | JP2006507246A (en) |
KR (1) | KR20050040928A (en) |
CN (1) | CN1678591A (en) |
AR (1) | AR043046A1 (en) |
AU (1) | AU2003258620A1 (en) |
BR (1) | BR0313790A (en) |
CA (1) | CA2496563A1 (en) |
DE (1) | DE10238865A1 (en) |
EA (1) | EA012834B1 (en) |
EC (1) | ECSP055615A (en) |
HR (1) | HRP20050179A2 (en) |
MX (1) | MXPA05002158A (en) |
NO (1) | NO20050068L (en) |
PE (1) | PE20040974A1 (en) |
PL (1) | PL375344A1 (en) |
RS (1) | RS20050173A (en) |
TW (1) | TW200413332A (en) |
UA (1) | UA82853C2 (en) |
WO (1) | WO2004024702A1 (en) |
ZA (1) | ZA200500086B (en) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7351719B2 (en) | 2002-10-31 | 2008-04-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
WO2004072018A1 (en) | 2003-02-12 | 2004-08-26 | Takeda Pharmaceutical Company Limited | Amine derivative |
KR20060060047A (en) | 2003-10-01 | 2006-06-02 | 더 프록터 앤드 갬블 캄파니 | Melanin concentrating hormone antagonists |
CA2541949A1 (en) * | 2003-10-07 | 2005-05-26 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
US7592373B2 (en) | 2003-12-23 | 2009-09-22 | Boehringer Ingelheim International Gmbh | Amide compounds with MCH antagonistic activity and medicaments comprising these compounds |
US7605176B2 (en) | 2004-03-06 | 2009-10-20 | Boehringer Ingelheim International Gmbh | β-ketoamide compounds with MCH antagonistic activity |
US7524862B2 (en) | 2004-04-14 | 2009-04-28 | Boehringer Ingelheim International Gmbh | Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds |
DE102004017934A1 (en) | 2004-04-14 | 2005-11-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New alkyne compounds having MCH antagonist activity and medicaments containing these compounds |
WO2005115389A2 (en) * | 2004-05-25 | 2005-12-08 | Pfizer Products Inc. | Specific ppar agonists for treating negative energy balance |
TW200613272A (en) | 2004-08-13 | 2006-05-01 | Astrazeneca Ab | Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
DE102004039789A1 (en) | 2004-08-16 | 2006-03-02 | Sanofi-Aventis Deutschland Gmbh | Aryl-substituted polycyclic amines, process for their preparation and their use as pharmaceuticals |
PL1836169T3 (en) * | 2004-12-28 | 2012-07-31 | Kinex Pharmaceuticals Llc | Compositions and methods of treating cell proliferation disorders |
US7968574B2 (en) | 2004-12-28 | 2011-06-28 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
WO2007021309A1 (en) * | 2005-08-12 | 2007-02-22 | Astrazeneca Ab | Substituted isoindolones and their use as metabotropic glutamate receptor potentiators |
US7807706B2 (en) | 2005-08-12 | 2010-10-05 | Astrazeneca Ab | Metabotropic glutamate-receptor-potentiating isoindolones |
RU2008129679A (en) | 2005-12-21 | 2010-01-27 | Янссен Фармацевтика Н.В. (Be) | NEW SUBSTITUTED PYRAZINONIC DERIVATIVES FOR USE IN SIT-1-MEDIATED DISEASES |
TW200804347A (en) | 2006-01-10 | 2008-01-16 | Janssen Pharmaceutica Nv | Urotensin II receptor antagonists |
CA2636879A1 (en) * | 2006-02-15 | 2007-08-23 | Sanofi-Aventis | Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
BRPI0707836A2 (en) | 2006-02-15 | 2011-05-10 | Sanofi Aventis | Substituted amino alcohol arylhydroisoquinolinines, process for their preparation and use as a medicament, medicament and process for their production |
CN101384583A (en) * | 2006-02-15 | 2009-03-11 | 塞诺菲-安万特股份有限公司 | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments |
BRPI0707869A2 (en) * | 2006-02-15 | 2011-05-10 | Sanofi Aventis | azacyclyl substituted arylthienopyrimidinones, process for their preparation and their use as medicines |
AU2007265373B2 (en) | 2006-06-29 | 2013-02-21 | Atnx Spv, Llc | Biaryl compositions and methods for modulating a kinase cascade |
TWI398440B (en) * | 2006-06-29 | 2013-06-11 | Kinex Pharmaceuticals Llc | Biaryl compositions and methods for modulating a kinase cascade |
WO2008016534A1 (en) | 2006-07-31 | 2008-02-07 | Janssen Pharmaceutica, N.V. | Urotensin ii receptor antagonists |
EP2383259A1 (en) | 2006-08-25 | 2011-11-02 | Boehringer Ingelheim International GmbH | New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds |
CA2664112C (en) | 2006-12-05 | 2015-02-17 | Janssen Pharmaceutica N.V. | Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases |
CL2007003580A1 (en) | 2006-12-11 | 2009-03-27 | Boehringer Ingelheim Int | Pyridazine derived compounds, mch antagonists; pharmaceutical composition comprising said compound; preparation procedure; and use of the compound in the treatment of metabolic disorders and / or eating disorders such as obesity, bulimia, anorexia, hyperphagia, diabetes. |
US7935697B2 (en) | 2006-12-28 | 2011-05-03 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
JP2010514837A (en) * | 2007-01-03 | 2010-05-06 | コーテックス ファーマシューティカルズ, インコーポレイテッド | 3-Substituted- [1,2,3] benzotriazinone compounds for enhancing glutamatergic synaptic responses |
DK2124562T3 (en) | 2007-03-09 | 2016-08-01 | Second Genome Inc | BICYCLOHETEROARYLFORBINDELSER AS P2X7 modulators and uses thereof |
TWI417100B (en) | 2007-06-07 | 2013-12-01 | Astrazeneca Ab | Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators-842 |
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
CN101412682B (en) * | 2007-10-19 | 2012-06-27 | 上海药明康德新药开发有限公司 | Process for synthesizing aryl anthranilic acid and derivatives thereof |
CN104016980B (en) * | 2008-04-23 | 2016-12-07 | 里格尔药品股份有限公司 | For treating the benzamide compound of dysbolismus |
SA109300358B1 (en) | 2008-06-06 | 2012-11-03 | استرازينيكا ايه بي | Isoindolone Metabotropic Glutamate receptor Potentiators |
US9079896B2 (en) | 2008-08-02 | 2015-07-14 | Janssen Pharmaceutica Nv | Urotensin II receptor antagonists |
TW201040153A (en) | 2009-02-13 | 2010-11-16 | Sanofi Aventis | Novel substituted tetrahydronaphthalenes, process for preparation thereof and use thereof as medicaments |
AR075401A1 (en) | 2009-02-13 | 2011-03-30 | Sanofi Aventis | SUBSTITUTED INDANS, PROCESSES FOR THEIR PREPARATION AND USE OF THE SAME AS A MEDICINAL PRODUCT |
CA2796419C (en) | 2010-04-16 | 2018-11-06 | Kinex Pharmaceuticals, Llc | Compositions and methods for the prevention and treatment of cancer |
GB201009853D0 (en) | 2010-06-11 | 2010-07-21 | Chroma Therapeutics Ltd | HSP90 inhibitors |
ES2785475T3 (en) * | 2011-05-10 | 2020-10-07 | Gilead Sciences Inc | Heterocyclic compounds fused as ion channel modulators |
NO3175985T3 (en) | 2011-07-01 | 2018-04-28 | ||
UY34171A (en) | 2011-07-01 | 2013-01-31 | Gilead Sciences Inc | FUSIONED HETEROCYCLIC COMPOUNDS AS IONIC CHANNEL MODULATORS |
UY34194A (en) * | 2011-07-15 | 2013-02-28 | Astrazeneca Ab | ? (3- (4- (SPIROHETEROCYCLIC) METHYL) PHENOXI) AZETIDIN-1-IL) (5- (PHENYL) -1,3,4-OXADIAZOL-2-IL) METHANONE IN THE TREATMENT OF OBESITY? |
US8933079B2 (en) * | 2012-03-07 | 2015-01-13 | Boehringer Ingelheim International Gmbh | Pyridone and pyridazinone derivatives as anti-obesity agents |
LT2890680T (en) | 2012-08-30 | 2018-05-10 | Athenex, Inc. | N-(3-fluorobenzyl)-2-(5-(4-morpholinophenyl)pyridin-2-yl) acetamide as protein tyrosine kinase modulators |
FR3000491B1 (en) * | 2012-09-27 | 2015-08-28 | Univ Lille Ii Droit & Sante | COMPOUNDS FOR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS |
CN110407824B (en) * | 2019-08-08 | 2021-07-02 | 安徽医科大学 | Aryl formamide compound and preparation method, pharmaceutical composition and application thereof |
JP2022549227A (en) * | 2019-09-17 | 2022-11-24 | バイアル-アールアンドディー インベストメンツ ソシエダッド アノニマ | Substituted saturated and unsaturated N-heterocyclic carboxamides and related compounds for use in treating medical disorders |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1218336A2 (en) * | 1999-09-20 | 2002-07-03 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonist |
WO2001087834A1 (en) * | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Melanin-concentrating hormone antagonist |
EP1299362A4 (en) * | 2000-07-05 | 2004-11-03 | Synaptic Pharma Corp | Selective melanin concentrating hormone-1 (mch1) receptor antagonists and uses thereof |
US20030022891A1 (en) * | 2000-12-01 | 2003-01-30 | Anandan Palani | MCH antagonists and their use in the treatment of obesity |
CA2431953A1 (en) * | 2000-12-22 | 2002-07-04 | Schering Corporation | Piperidine mch antagonists and their use in the treatment of obesity |
GB0124627D0 (en) * | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
GB0124931D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
-
2002
- 2002-08-24 DE DE10238865A patent/DE10238865A1/en not_active Withdrawn
-
2003
- 2003-08-16 RS YUP-2005/0173A patent/RS20050173A/en unknown
- 2003-08-16 CN CNA038200767A patent/CN1678591A/en active Pending
- 2003-08-16 WO PCT/EP2003/009099 patent/WO2004024702A1/en active Application Filing
- 2003-08-16 CA CA002496563A patent/CA2496563A1/en not_active Abandoned
- 2003-08-16 JP JP2004535098A patent/JP2006507246A/en active Pending
- 2003-08-16 AU AU2003258620A patent/AU2003258620A1/en not_active Abandoned
- 2003-08-16 EA EA200500301A patent/EA012834B1/en not_active IP Right Cessation
- 2003-08-16 KR KR1020057003110A patent/KR20050040928A/en not_active Application Discontinuation
- 2003-08-16 PL PL03375344A patent/PL375344A1/en not_active Application Discontinuation
- 2003-08-16 EP EP03794886A patent/EP1534689A1/en not_active Withdrawn
- 2003-08-16 BR BR0313790-2A patent/BR0313790A/en not_active Expired - Fee Related
- 2003-08-16 MX MXPA05002158A patent/MXPA05002158A/en unknown
- 2003-08-16 UA UAA200502601A patent/UA82853C2/en unknown
- 2003-08-21 PE PE2003000849A patent/PE20040974A1/en not_active Application Discontinuation
- 2003-08-22 AR ARP030103034A patent/AR043046A1/en unknown
- 2003-08-22 TW TW092123197A patent/TW200413332A/en unknown
-
2005
- 2005-01-05 ZA ZA200500086A patent/ZA200500086B/en unknown
- 2005-01-06 NO NO20050068A patent/NO20050068L/en not_active Application Discontinuation
- 2005-02-18 EC EC2005005615A patent/ECSP055615A/en unknown
- 2005-02-23 HR HR20050179A patent/HRP20050179A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ECSP055615A (en) | 2005-05-30 |
CA2496563A1 (en) | 2004-03-25 |
KR20050040928A (en) | 2005-05-03 |
BR0313790A (en) | 2005-07-12 |
AU2003258620A1 (en) | 2004-04-30 |
DE10238865A1 (en) | 2004-03-11 |
EP1534689A1 (en) | 2005-06-01 |
ZA200500086B (en) | 2006-07-26 |
JP2006507246A (en) | 2006-03-02 |
HRP20050179A2 (en) | 2006-05-31 |
MXPA05002158A (en) | 2005-05-23 |
EA200500301A1 (en) | 2006-02-24 |
EA012834B1 (en) | 2009-12-30 |
RS20050173A (en) | 2007-09-21 |
CN1678591A (en) | 2005-10-05 |
UA82853C2 (en) | 2008-05-26 |
PL375344A1 (en) | 2005-11-28 |
NO20050068L (en) | 2005-03-04 |
WO2004024702A1 (en) | 2004-03-25 |
TW200413332A (en) | 2004-08-01 |
PE20040974A1 (en) | 2005-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR043046A1 (en) | AMBO COMPOUNDS OF CARBOXILIC ACID WITH ANTAGONIC EFFECT OF HCM, MEDICATIONS CONTAINING THESE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION | |
AR041734A1 (en) | ALKIN COMPOUNDS WITH ANTAGONIC EFFECT OF HCM AND MEDICINES CONTAINING THESE COMPOUNDS | |
AR041735A1 (en) | AMIDA COMPOUNDS WITH MCH ANTAGONIST ACTION AND MEDICINES CONTAINING THESE COMPOUNDS | |
AR048691A1 (en) | COMPOUNDS WITH ALQUINO STRUCTURE WITH MCH ANTAGONIST ACTION AND MEDICINES CONTAINING THESE COMPOUNDS | |
AR087760A1 (en) | HETEROCICLILAMINAS AS PI3K INHIBITORS | |
AR076435A1 (en) | COMPOUNDS OF REPLACED INDAZOLS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCESSES TO OBTAIN THEMSELVES | |
AR058287A1 (en) | ISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | |
AR037235A1 (en) | DERIVATIVES OF SULFONAMIDE, DRUGS CONTAINING THEM AND THE USE OF SUCH DERIVATIVES FOR THE PREPARATION OF DRUGS | |
RU2014141579A (en) | Heterocyclic compounds as beta-lactamase inhibitors | |
AR040476A1 (en) | N-CICLOALQUIL, ARIL OR HETEROARIL N'-QUINOLIN-2-IL ALQUILDIAMINAS AND ITS USE AS AN ANCHORIST OF MCH (MELANINE CONCENTRATING HORMONE) | |
AR095192A1 (en) | QUINOLINA AND QUINAZOLINAMIDAS AS MODULAR SODIUM CHANNELS | |
AR079541A1 (en) | SUBSTITUTED COMPOUNDS OF N- (1H-INDAZOL-4-IL) IMIDAZO (1,2-A) PIRIDIN-3-CARBOXAMIDE AS CFMS INHIBITORS | |
ECSP034475A (en) | DERIVATIVES OF 4-PHENYL-PIRIDIN AS ANTAGONISTS OF THE NEUROQUININE RECEIVER-1 | |
EA200600257A1 (en) | DERIVATIVES OF TRIAZOLOPYRIMIDINE AS KINASE GLYCOGENSINTAZY-3 KINASE INHIBITORS | |
AR086983A1 (en) | DERIVATIVES OF AZETIDINIL FENIL, PIRIDIL OR PIRAZINIL CARBOXAMIDA AS JAK INHIBITORS | |
AR040595A1 (en) | DERIVATIVES OF REPLACED AMINA AND METHODS OF USE | |
AR082152A1 (en) | DERIVATIVES OF N- (METILSULFONIL) BENZAMIDE, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE INHIBITION OF NAV1.7 | |
AR090548A1 (en) | BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS | |
AR079553A1 (en) | DERIVATIVES OF DIAZA-ESPIRO- [5,5] -UNDECANOS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME IN THE TREATMENT OF CNS DISORDERS, SUCH AS DISORDERS OF THE SOUND AND DEPENDENCY, AMONG OTHERS. | |
AR037008A1 (en) | THE USE OF THE NK-1 RECEIVER ANTAGONIST FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT AND / OR PREVENTION OF BRAIN, SPINAL OR NEURONAL INJURIES AND A PHARMACEUTICAL COMPOSITION THAT INCLUDES ONE OR MORE OF SUCH ANTAGONIST. | |
AR064547A1 (en) | DERIVATIVES OF AZASPIRO AS ANTAGONISTS OF THE V1A RECEIVER | |
AR060840A1 (en) | VR1 BENCIMIDAZOLIC MODULATORS | |
AR064293A1 (en) | PIRIDAZINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USES TO PREVENT AND / OR TREAT DISEASES ASSOCIATED WITH MELANINE CONCENTRATING HORMONE: MCH. | |
AR077463A1 (en) | IMIDAZO DERIVATIVES [1, 2 - A] PIRAZINA AND ITS USE IN MEDICINES FOR THE TREATMENT OF PARASITARY DISEASES | |
AR067975A1 (en) | DERIVATIVES OF N-BENCIL, N-ARILCARBONILPIPERAZINA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |